AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Net income margin (%)

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥555.1B
P/E ratio
17.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
May 31, 20253.1+20.87%
May 31, 20242.5-11.86%
May 31, 20232.9-6.20%
May 31, 20223.1-18.01%
May 31, 20213.7+19.36%
May 31, 20203.1-0.23%
May 31, 20193.1-0.66%
May 31, 20183.2-12.78%
May 31, 20173.6+30.32%
May 31, 20162.8-2.89%
May 31, 20152.9+0.42%
May 31, 20142.9-0.08%
May 31, 20132.9+2.90%
May 31, 20122.8+14.64%
May 31, 20112.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)